-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2019 to Q4 2024.
- Taysha Gene Therapies, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$18.8M, a 139% decline year-over-year.
- Taysha Gene Therapies, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$89.3M, a 20% increase year-over-year.
- Taysha Gene Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$89.3M, a 20% increase from 2023.
- Taysha Gene Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$112M, a 32.8% increase from 2022.
- Taysha Gene Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$166M, a 4.88% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)